Topoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer
Tommaso Susini(Unknown), Simonetta Bianchi(University of Florence), Valeria Saladino(Magna Graecia University), Cecilia Molino(University of Florence), Jacopo Nori(Azienda Ospedaliero-Universitaria Careggi), Carlo Carriero(University of Florence), Ermanno Vanzi(Azienda Ospedaliero-Universitaria Careggi), Mariarosaria Di Tommaso(University of Florence), Marco Santini(University of Florence), Ketty Tavella(Chemotherapy Foundation)
Cited by 13
Related Papers
The Psychological and Social Impact of Covid-19: New Perspectives of Well-Being
|Frontiers in Psychology|2020|644
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
|Journal of Hepatology|2018|133
Gluten intolerance: Gender- and age-related differences in symptoms
|Scandinavian Journal of Gastroenterology|2005|83
Prevalence of celiac disease in inflammatory bowel diseases: An IG-IBD multicentre study
|Digestive and Liver Disease|2009|83
Identity, relationships, sexuality, and risky behaviors of adolescents in the context of social media
|Sexual & Relationship Therapy|2017|77